Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Quality of Life × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thymus Neoplasms 1 Sarcoma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Hematologic Diseases 1 Glioma 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bone Neoplasms 1 Bone Marrow Diseases 1 Adenocarcinoma 1

Interventions

Specimen Handling 6 Cyclophosphamide 5 Biopsy 5 Temozolomide 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 pazopanib 3 X-Rays 3 Vincristine 3 Trabectedin 3 Irinotecan 3 Ifosfamide 3 Doxorubicin 3 regorafenib 2 pembrolizumab 2 fludarabine 2 atezolizumab 2 Sirolimus 2 Radiation 2 Phantoms, Imaging 2 Metastasectomy 2 Interleukin-15 2 Gemcitabine 2 Etoposide 2 trastuzumab deruxtecan 1 tivozanib 1 temsirolimus 1 tazemetostat 1 talimogene laherparepvec 1 selinexor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05051059 2026-03-16

QOLSarcoma

Universitaire Ziekenhuizen KU Leuven

Phase NA Recruiting

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡